Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 7 studies | 27% ± 10% | |
| oligodendrocyte precursor cell | 5 studies | 32% ± 11% | |
| type II pneumocyte | 5 studies | 31% ± 6% | |
| glutamatergic neuron | 4 studies | 37% ± 16% | |
| ciliated cell | 3 studies | 22% ± 2% | |
| retinal cone cell | 3 studies | 18% ± 4% | |
| GABAergic neuron | 3 studies | 42% ± 6% | |
| ependymal cell | 3 studies | 45% ± 13% | |
| oligodendrocyte | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1122.20 | 2638 / 2642 | 98% | 6.26 | 688 / 705 |
| prostate | 100% | 616.54 | 244 / 245 | 96% | 2.02 | 484 / 502 |
| thymus | 100% | 656.23 | 653 / 653 | 89% | 2.90 | 540 / 605 |
| kidney | 100% | 457.99 | 89 / 89 | 77% | 1.75 | 693 / 901 |
| adrenal gland | 95% | 309.72 | 246 / 258 | 81% | 2.46 | 187 / 230 |
| breast | 93% | 288.25 | 428 / 459 | 65% | 1.33 | 732 / 1118 |
| ovary | 100% | 1160.52 | 180 / 180 | 50% | 1.08 | 213 / 430 |
| pancreas | 98% | 317.00 | 323 / 328 | 51% | 1.00 | 90 / 178 |
| lung | 99% | 813.05 | 575 / 578 | 44% | 1.22 | 506 / 1155 |
| skin | 88% | 222.43 | 1597 / 1809 | 47% | 0.84 | 221 / 472 |
| uterus | 98% | 426.31 | 167 / 170 | 32% | 0.62 | 147 / 459 |
| esophagus | 85% | 351.30 | 1229 / 1445 | 45% | 0.72 | 82 / 183 |
| bladder | 100% | 351.90 | 21 / 21 | 25% | 0.56 | 126 / 504 |
| intestine | 97% | 437.43 | 934 / 966 | 24% | 0.41 | 127 / 527 |
| stomach | 82% | 217.36 | 294 / 359 | 20% | 0.45 | 57 / 286 |
| spleen | 100% | 439.49 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 664.61 | 1326 / 1335 | 0% | 0 | 0 / 0 |
| heart | 94% | 368.73 | 811 / 861 | 0% | 0 | 0 / 0 |
| muscle | 90% | 272.11 | 724 / 803 | 0% | 0 | 0 / 0 |
| adipose | 89% | 237.16 | 1066 / 1204 | 0% | 0 | 0 / 0 |
| liver | 50% | 94.96 | 113 / 226 | 7% | 0.11 | 30 / 406 |
| eye | 0% | 0 | 0 / 0 | 44% | 1.28 | 35 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.27 | 6 / 29 |
| peripheral blood | 20% | 195.41 | 182 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.12 | 4 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LRP2BP |
| Protein name | LRP2-binding protein (Megalin-binding protein) (MegBP) LRP2-binding protein |
| Synonyms | hCG_16628 KIAA1325 |
| Description | FUNCTION: May act as an adapter that regulates LRP2 function. FUNCTION: May act as an adapter that regulates LRP2 function. . FUNCTION: May act as an adapter that regulates LRP2 function. . |
| Accessions | D6RGF6 ENST00000510776.5 Q9P2M1 ENST00000511404.1 ENST00000328559.11 [Q9P2M1-1] G5E9Z9 ENST00000505916.6 [Q9P2M1-1] |